QA: Gossamer Bio Inc in us_pharma/2024

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001728117_2025_Gossamer_Bio_Inc.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001728117, Gossamer Bio Inc

  xvar xval
0 AssetsCurrent 309,888,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 10,000
3 remainder_Assets 5,394,000
4 LiabilitiesCurrent 45,010,000
5 LiabilitiesNoncurrent 43,267,000
6 remainder_Liabilities 197,523,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 36,133,000
9 ResearchAndDevelopmentExpense 138,487,000
10 remainder_Expenses 893,000
11 remainder_Revenues 114,701,000
12 remainder_NetIncome 4,284,000
13 remainder_ComprehensiveNetIncome 1,539,000
  yvar yval
0 Assets 315,292,000
1 Liabilities 285,800,000
2 Expenses 175,513,000
3 Revenues 114,701,000
4 StockholdersEquity 29,492,000
5 NetIncome -56,528,000
6 ComprehensiveNetIncome -55,758,500
7 BaseVar 448,564,500
8 EconomicCapitalRatiobeforeLimitedLiability 0.0284
9 EconomicCapitalRatio 1.44

Edgar->Model Mapping

Feature Distribution

Change over Time